Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4701
Tejon Ranch
TRC
$467M
| $2.04M | ﹤0.01% |
129,550
-6,140
| -5% | -$97.9K |
|
4702
Citi Trends
CTRN
$559M
| $2.03M | ﹤0.01% |
48,929
-14,927
| -23% | -$589K |
|
4703
AdvisorShares Pure US Cannabis ETF
MSOS
$830M
| $2.03M | ﹤0.01% |
429,028
-341,697
| -44% | -$1.52M |
|
4704
Invesco Active US Real Estate Fund
PSR
$60.6M
| $2.02M | ﹤0.01% |
22,366
+154
| +0.7% | +$14.1K |
|
|
EOT
4705
Eaton Vance National Municipal Opportunities Trust
EOT
$269M
| $2.02M | ﹤0.01% |
119,398
+3,838
| +3% | +$64.1K |
|
4706
OptimizeRx
OPRX
$119M
| $2.02M | ﹤0.01% |
164,592
-17,686
| -10% | -$289K |
|
|
EOD
4707
Allspring Global Dividend Opportunity Fund
EOD
$275M
| $2.01M | ﹤0.01% |
344,635
+11,824
| +4% | +$68.4K |
|
|
AAAC
4708
Columbia AAA CLO ETF
AAAC
$104M
| $2.01M | ﹤0.01% |
+100,000
| New | +$2M |
|
|
NFBK
4709
DELISTED
Northfield Bancorp
NFBK
| $2M | ﹤0.01% |
175,255
+35,149
| +25% | +$389K |
|
|
CCRP
4710
Columbia Corporate Bond ETF
CCRP
$54.5M
| $2M | ﹤0.01% |
+100,000
| New | +$2M |
|
4711
Biglari Holdings Class B
BH
$1.18B
| $2M | ﹤0.01% |
6,001
-8,561
| -59% | -$2.87M |
|
4712
Global X SuperIncome Preferred ETF
SPFF
$140M
| $1.99M | ﹤0.01% |
213,823
+13,172
| +7% | +$122K |
|
4713
Invesco Dorsey Wright Basic Materials Momentum ETF
PYZ
$73.4M
| $1.99M | ﹤0.01% |
18,082
-2,150
| -11% | -$230K |
|
|
BTA
4714
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
| $1.98M | ﹤0.01% |
213,840
-9,758
| -4% | -$92.5K |
|
4715
John Wiley & Sons Class B
WLYB
$2.63B
| $1.98M | ﹤0.01% |
65,006
| – | – |
|
|
IAUX
4716
i-80 Gold Corp
IAUX
$1.11B
| $1.98M | ﹤0.01% |
1,356,397
+971,330
| +252% | +$1.1M |
|
4717
Xtrackers Municipal Infrastructure Revenue Bond ETF
RVNU
$143M
| $1.98M | ﹤0.01% |
80,693
-9,416
| -10% | -$233K |
|
4718
Akebia Therapeutics
AKBA
$341M
| $1.98M | ﹤0.01% |
1,228,816
-3,086,385
| -72% | -$6.46M |
|
4719
ProShares UltraPro Short QQQ
SQQQ
$2.17B
| $1.98M | ﹤0.01% |
28,848
+15,539
| +117% | +$1.1M |
|
4720
WisdomTree US Multifactor Fund
USMF
$298M
| $1.98M | ﹤0.01% |
38,536
-43,770
| -53% | -$2.24M |
|
|
SLN
4721
Silence Therapeutics
SLN
$546M
| $1.97M | ﹤0.01% |
324,630
-883,094
| -73% | -$5.65M |
|
|
TECX
4722
Tectonic Therapeutic
TECX
$562M
| $1.97M | ﹤0.01% |
94,435
-10,298
| -10% | -$191K |
|
4723
NN Inc
NNBR
$261M
| $1.97M | ﹤0.01% |
1,537,171
-39,439
| -3% | -$60.3K |
|
4724
ArriVent BioPharma
AVBP
$1.4B
| $1.96M | ﹤0.01% |
97,590
-294,432
| -75% | -$6.13M |
|
|
ALM
4725
Almonty Industries
ALM
$3.47B
| $1.96M | ﹤0.01% |
222,666
+179,164
| +412% | +$1.32M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.